Clinical TrialID 402

Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy

NCT00608439

Diabetic Neuropathy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
402
Evidence Id
402
Core Evidence Id
402
Source Clinical Trial Id
388
Herb2 Clinical Trial Id
HBCT000388
Nct Id
NCT00608439
Title
Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Diabetic Neuropathy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Centella asiatica selected triterpenes (CAST)|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Single_Group
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
43
Outcome Measure
Total Symptom Score, one year
Sponsor Collaborator
Oregon Health and Science University|National Center for Complementary and Integrative Health (NCCIH)
Funded By
OTHER
Location
Oregon Health and Science University, Portland, Oregon, 97239, United States
Other Id
R21AT003668|R21AT003668
Start Date
2007-09
Primary Completion Date
2011-08
Completion Date
2011-08
First Posted
2008-02-06
Results First Posted
Last Update Posted
2012-11-12
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00608439
Title Cn
Title En
Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy
Bilingual Status
semi_complete